Geneva Partners’s Steris STE Stock Holding History

Geneva Partners’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-950	Closed	-$230K	–	74
2022 Q1	$230K	Sell	950 -8,215	-90%	-$1.9M	0.14%	72
2021 Q4	$2.23M	Buy	+9,165	New	+$2.09M	1.06%	31

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geneva Partners's STE Position: Q2 2022 in Review

Geneva Partners sold out of Steris (STE) in Q2 2022, closing a stake of 950 shares — an estimated $230K sold.

Geneva Partners first reported a position in STE in Q4 2021 and held it in 2 quarters. The position peaked at $2.23M in Q4 2021. 665 funds tracked by Wall St. Rank hold STE as of Q2 2022.

Geneva Partners reported no remaining Steris position as of Q2 2022 after selling out during the quarter.
Geneva Partners sold 950 Steris shares in Q2 2022, an estimated $230K.
Geneva Partners first reported a position in Steris in Q4 2021 and held it in 2 quarters.
Geneva Partners's Steris position peaked at $2.23M in Q4 2021.
665 funds tracked by Wall St. Rank held Steris as of Q2 2022.

Based on Geneva Partners's 13F filing for Q2 2022, filed 25 Jul 2022.